ARTAN Bio Secures $1M Seed Round for tRNA Platform
ST. PETERSBURG, Fla., July 1, 2026 ARTAN Bio has announced the successful completion of a $1 million seed financing...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
ST. PETERSBURG, Fla., July 1, 2026 ARTAN Bio has announced the successful completion of a $1 million seed financing...
EINDHOVEN, The Netherlands | January 7, 2026 — ShanX Medtech announced the successful close of a €24 million financing...
SAN FRANCISCO, December 3, 2025 — Junevity today announced the expansion of its seed funding round to $20 million...
